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Introduction
In our days, implant treatment of toothless is the most 
elected method. Chele et al. propose the immediate post ex-
traction implant placement [1], however, in cases of alveolar 
ridge deficiency additional bone growth is needed. In 2016, 
Knofler W. et al. showed that bone growth procedures as-
sociated with dental implants are required in 58.2% of cas-
es [2]. Postoperative healing after bone grafting is directly 
influenced by the general condition of the body. Thus, in 
addition to the thorough study of the affected area, the as-
sessment of the patient’s general condition and concomitant 
diseases are equally important for the rehabilitation of eden-
tulous patients with severe mandibular atrophy.
A multitude of alveolar grafting methods are proposed 
in preimplantation. In literature, there are studies on guided 
bone regeneration, which is the most widely used method of 
alveolar grafting showing high efficacy [3].
Guided bone regeneration (GBR) is an extremely deli-
cate procedure that relies on body’s ability of self-healing. 
Therefore, patients with poor healing potential cannot un-
dergo GBR procedures. Systemic conditions that may im-
pede the patient to undergo surgery include a number of 
general medical conditions such as: uncontrolled diabetes 
mellitus, tumors, recent radiation of the head and neck re-
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Abstract
Objectives: To present the survey questionnaire used for the medical assessment of patients requiring alveolar ridge reconstruction as well as the study 
of concomitant pathologies and their influence on the healing process.
Material and methods: The study involved 173 patients aged between 18 and 69 years. All patients have been assessed according to the survey questionnaire 
developed to determine the patient’s general condition, life anamnesis, and medical history.
Results: Out of the total of 173 patients, 72 (41.6%) had no concomitant pathologies, 8 patients (4.6%) had concomitant pathologies that did not interfere 
with the operation, 40 (23.1%) had pathologies that might affect the outcome of alveolar ridge reconstruction but still were admitted to surgery, and 53 
patients (30.6%) had pathologies that could affect the outcome of the reconstruction procedure and were not admitted to bone grafting.
Conclusions: Assessment of patients with alveolar ridge defects during preparation and planning of preimplantation bone reconstruction identified a 
number of concomitant pathologies, more or less noticed by the patient, which may remain unclear due to superficial study of the patient’s condition that 
is able to influence the surgical treatment outcome. These issues can be both intraoperative and postoperative and lead to failure of surgical treatment 
and further reoperation.
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gion, acquired immunodeficiency syndrome (AIDS) or oth-
er conditions that cause immunosuppression, decompen-
sated systemic conditions, cardio-vascular diseases, etc. [4]. 
Cardiovascular diseases are systemic conditions that highly 
affect tissue regeneration as they disrupt the nutrition and 
oxygenation of tissues through vascular damage. These types 
of diseases are extensively evaluated while preparing patients 
for preimplantation. Cardiovascular diseases are among the 
most common systemic conditions. Patients with cardio-
vascular diseases may develop medical conditions such as: 
congestive heart failure, angina pectoris, myocardial infarc-
tion, cardiac arrhythmia, heart valve prosthesis, pacemaker, 
hypertension, anticoagulant addiction, and post-extraction 
dental hemorrhage (PDH) [5].
Patients may also suffer from general diseases and con-
ditions such as: infectious endocarditis, diabetes mellitus, 
osteoporosis, hormonal medication, radiotherapy, gastro-
esophageal reflux disease (GERD), systemic lupus erythe-
matosus, HIV infection, smoking status, and stress. All these 
diseases may have a different impact on alveolar ridge recon-
struction. Often, because of the focus on local diseases doc-
tors neglect the assessment of body’s general condition. A 
general pathology may go unnoticed if the patient does not 
communicate about it. All causes mentioned above, as well 
as superficial examination of the patient can generate poor 
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results and failure of clinical outcomes. Thus, it is imperative 
to detect concomitant pathologies and study their impact on 
alveolar ridge reconstruction. 
 This study is to assess the general medical condition of 
patients requiring alveolar ridge reconstruction. To study 
the concomitant pathologies and their influence on the hea-
ling process after bone grafting.
Material and methods
The study took place between 2016 and 2020. There were 
assessed 173 patients aged between 18 and 69 years and the 
mean age constituted 46.7±0.3 years (84 men and 89 women).
All patients have been assessed according to a survey 
questionnaire that was developed to determine the patient’s 
general condition, life anamnesis, and medical history. The 
first part contains information about the patient’s personal 
data. The second part is filled in by the doctor and contains 
information about oral hygiene, smoking status, smile line 
and aesthetic expectations of the patient. The third part of 
the survey questionnaire contains a set of questions to which 
the patient answers by ticking the options, if necessary; ad-
ditionally it states information about the disease.
List of patient’s questions:
Ø Do you suffer/ have you suffered from any acute or 
chronic diseases?
Ø Do you suffer/ have you suffered from: disorders of 
the immune system; allergies or drug/nonmedicinal 
intolerances; hypertension; vascular diseases; heart 
disease; respiratory diseases; gastrointestinal diseases; 
hepatobiliary diseases; kidney and/or urinary diseas-
es; neurological diseases; mental illness; eye diseases; 
hematological diseases; endocrine diseases; diseases 
of the skeleton; diseases of the skin and mucous mem-
branes; tumors; obstructive sleep apnea?
Ø Are you following any treatment (medicinal, homeo-
pathic, phytotherapy)?
Ø Have you been on any treatment with: antibiotic in the 
last month, anticoagulants, or bisphosphonates?
Ø Are you having difficulty breathing?
Ø Do you have / have you had any vicious habits?
Ø Have you undergone any surgery in your lifetime?
Ø Have you had dental treatment before?
Ø Have accidents/incidents or complications occurred in 
previous dental treatments?
Ø Have you ever donated blood?
Ø Are you pregnant?
In the study all patients have had severe alveolar ridge 
atrophy requiring reconstruction and further implant-pros-
thetic rehabilitation. By using the survey questionnaire, the 
presence or absence of general pathologies was evaluated 
and some of the patients were accepted for bone grafting. 
Other patients were not engaged in bone reconstruction sur-
gery because of concomitant pathologies occurrence associ-
ated with absolute contraindications. The selected patients 
were assessed according to evaluating postoperative healing 
parameters at 7 days, 21 days, and 6 months (implantation 
stage). The influence of general pathology on healing pro-
cess was also taken into account. The healing parameters 
were: wound dehiscence, mucosal erosion, and graft expo-
sure. These parameters have been analyzed after clinical and 
paraclinical aspects by using pictures. The data obtained was 
entered into a Microsoft Excel table and analyzed statistically 
using IBM SPSS Statistics 22.
Results and discussion
Out of the total 173 patients, 72 (41.6%) had no concom-
itant pathologies, 8 patients (4.6%) had concomitant pathol-
ogies that did not interfere with the operation, 40 (23.1%) 
had pathologies that could affect the outcome of alveolar 
ridge reconstruction but still were admitted to intervention, 
and 53 patients (30.6%) had pathologies that could affect 
the outcome of the reconstruction and were not admitted 
to bone grafting. 53 (100%) patients who were not admitted 
to bone reconstruction had the following general patholo-
gies and vices (tab.1.): osteoporosis treated with  intravenous 
bisphosphonates (3-5.7%), cardiopathies or angiopathies 
treated with oral anticoagulants (7-13.2%), compensated 
or decompensated diabetes mellitus (14-26.4%), long-term 
treatment of pemphigus with corticosteroids that decreas-
es osteogenesis and creates immunosuppression (1-1.9%), 
long-term treatment of osteoarthritis with corticosteroids 
that decreases osteogenesis and creates immunosuppression 
(2-3.8%), radiotherapy performed no less than 12 months 
after the last cure (5-9.3%), chemotherapy performed no 
less than 6 months after the last cure (3-5.7%), rheumatoid 
arthritis treated with cytostatic (7-13.2%), hemophilia (2-
3.8%), non-compliant heavy smokers (more than 10 ciga-
rettes/day) (8-15.1%), after use of intravenous phosphate 
drugs (current consumption in suspension) (1-1.9%).
table 1.  Patients with general pathologies and 
unaccepted vices for bone reconstruction





Osteoporosis treated with intravenous 
bisphosphonates
3 5.7%
Cardiopathies or angiopathies treated with 
oral anticoagulants
7 13.2%
Compensated or decompensated diabetes 
mellitus
14 26.4%
Long-term treatment of pemphigus with 
corticosteroids
1 1.9%
Long-term treatment of osteoarthritis with 
corticosteroids
2 3.8%
Radiotherapy /no less than 12 months after 
the last cure
5 9.3%
Chemotherapy /no less than 6 months after 
the last cure
3 5.7%
Rheumatoid arthritis treated with cytostatic 7 13.2%
Hemophilia 2 3.8%
Non-compliant heavy smokers 8 15.1%






ORIGINAL  ReseARch A. Ghetiu. Moldovan Medical Journal. October 2021;64(4):29-34
 
40 patients (100%) had pathologies and vices that could 
affect the outcome of alveolar ridge reconstruction but still 
were admitted to intervention (tab. 2). These pathologies are: 
hyperparathyroidism (osteoporosis) (1-2.5%), hypothyroid-
ism (osteoporosis) (4-10%), Crohn's disease (osteoporosis 
caused by malabsorption of D2 and calcium in the intestine) 
(2-5%), gastroesophageal reflux disease (5-12.5%), compen-
sated diabetes (18-45%), and light smokers (up to 10 cig/
day) (10-25%).
table 2. Patients with general pathologies and vices 















Hyperparathyroidism 1 2.5% 0 – 0% 1 – 2.5%
Hypothyroidism 4 10% 1 – 2.5% 0 – 0%
Crohn’s disease 2 5% 0 – 0% 0 – 0%
Gastrointestinal 
reflux disease
5 12.5% 2 – 5% 1 – 2.5%
Compensated dia-
betes
18 45% 6 – 15% 1 – 2.5%
Light smokers 10 25% 3 – 7.5% 1 – 2.5%
Total 40 100% 12 – 30% 4 – 10%
Other 8 (100%) patients had the following concomitant 
pathologies that did not interfere with alveolar ridge recon-
struction (tab. 3): drug allergy (3-37.5%), hepatitis B infec-
tion (2-25%), chronic bronchitis (2-25%), and renal lithiasis 
(1-12.5%).
table 3. Patients with concomitant pathologies that do 















Drug allergy 3 – 37.5% 37.5% 0 0
Hepatitis B 2 – 25% 25% 0 0
Chronic bronchitis 2 – 25% 25% 0 0
Renal lithiasis 1 – 12.5% 12.5% 0 0
Total 8 patients 100% 0% 0%
The majority of patients (72) admitted to surgery did not 
have concomitant pathologies or vices (tab. 4).
table 4. Patients without concomitant pathologies  










Erosion of the 
mucosa with 
graft exposure
No pathologies 72 100% 1 – 1.4% 5 – 7%
The presence of complications was studied in patients 
who underwent alveolar ridge reconstruction. Concomitant 
pathology which is influencing the outcome of alveolar ridge 
reconstruction can lead to high rate of exacerbations. Thus, 
out of 72 patients (100%), 1 patient (1.4%) had wound de-
hiscence and 5 patients (7%) had mucosal erosion with graft 
exposure. All these patients, who experienced complications 
were completely healthy without concomitant pathologies. 
Patients with general pathologies that did not influence bone 
reconstruction (8 patients) had no postoperative complica-
tions. 40 (100%) patients who had pathologies that could 
affect the outcome of alveolar ridge reconstruction showed 
wound dehiscence in 12 cases (30%) and erosion of the mu-
cosa with graft exposure in 4 cases (10%).
The positive outcome of bone reconstruction surgery is 
closely related to bone structure characteristics. Bone tissue 
is a dynamic highly organized structure that can be remod-
eled according to mechanical stress and hormonal activity. 
The resorbed bone is replaced by the forming cells and the 
bone neoformation, which lasts approximately 3 months [6]. 
Another component of the positive outcome of bone recon-
struction procedures is related to body condition when vari-
ous intra- and postoperative complications may occur but 
they are not directly related to bone healing. These condi-
tions and their management are described below [7].
Some cardiovascular pathologies are treated with anti-
coagulant medication. These can lead to immediate and de-
layed complications with harmful consequences or alveolar 
ridge reconstruction failure. Zanoaga O. et al. showed that 
dental extractions can be carried out without cancelling the 
administration of antithrombotic drugs [8]. Two classes 
of new oral anticoagulants are currently available for this 
purpose: thrombin inhibitors (dabigatran) and factor Xa 
inhibitors (rivaroxaban, apixaban, edoxaban). Unlike vita-
min K inhibitors (acenocoumarol, warfarin), which block 
the formation of several active vitamin K-dependent factors 
(factors II, VII, IX and X), new oral anticoagulants block 
the activity of a single factor in the blood clotting cascade 
[8]. These new oral anticoagulants are: Dabigatran etexilate 
(brand name Pradaxa), Rivaroxaban (brand name Xarelto), 
Apixaban (brand name Eliquis), and Edoxaban (brand name 
Lixiana). 
Cardiac pathology and increased risk of endocarditis 
should be considered in the oral surgical patient. Patients 
with valvular prostheses, history of infectious endocardi-
tis, as well as those with cyanogenic congenital  heart dis-
ease  may develop infectious endocarditis, which remains 
a severe form of valvular dysfunction associated with poor 
prognosis and high mortality.  In 2018, Zanoaga O.  showed 
that dentoalveolar surgery requires prophylaxis of the infec-
tive endocarditis [9].
Glucose metabolism disease influences the tissue heal-
ing. Uncontrolled diabetes was associated with greater vari-
ability and increased rate of infectious complications in al-
veolar ridge reconstructions; insulin-mediated metabolic 
control can reverse these adverse effects [10].
The high rate of complications, such as resorption, non-
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integration and delayed healing of bone graft, especially 
in the upper jaw, can occur in patients with osteoporosis. 
Generally, osteoporosis is not a contraindication for bone 
augmentation and placement of dental implants. Although, 
an increase of risk factors and complications can be expect-
ed in patients with osteoporosis [11]. A number of thera-
peutic approaches have been proposed to accelerate bone 
healing and prevent complications in bone grafting. These 
treatments include bisphosphonates, hormone replacement 
therapy (HRT), calcitonin, diet high in vitamins and calcium 
supplements [12]. The cornerstone of osteoporosis preven-
tion and treatment is the provision of adequate intake of cal-
cium, vitamin D and weight-bearing exercises. It is known 
that mechanical demand produces an increase of the cellular 
metabolism and collagen synthesis. There are studies show-
ing that physical exercises are beneficial for preventing bone 
loss in postmenopausal women. Smoking is a risk factor for 
osteoporosis and is also associated with high rate of implant 
failure [13]. A combination of osteoporosis and tobacco in-
take leads to a high complication rate, thus, quitting smok-
ing is imperative for a positive outcome of bone reconstruc-
tion in patients with osteoporosis. Other risk factors for os-
teoporosis are the use of corticosteroids and increased con-
sumption of alcohol and caffeine. Patients with osteoporosis 
should be encouraged to reduce alcohol and caffeine intake 
before dental implant surgery or bone grafting.
Currently, it is unknown if the use of systemic bisphos-
phonates for the treatment of osteoporosis influences di-
rectly or indirectly the capacity of guided bone regeneration 
(GBR) techniques [14]. Bisphosphonates are the synthetic 
analogues of inorganic pyrophosphate. The most common 
oral drugs used in the treatment of osteoporosis are: alen-
dronate, risedronate and ibandronate. They have been shown 
to reduce osteoclast activity and therefore bone resorption 
[15]. Recently, bisphosphonates have been associated with 
jaw osteonecrosis. Most cases of necrosis are, however, as-
sociated with intravenous administration of high doses of 
pamidronate and zoledronate, which are commonly used for 
bone metastases treatment in multiple myeloma and breast 
cancer. Treatment with oral bisphosphonates may be consid-
ered as risk factor for osteonecrosis [16].
 In 2008, Radzichevici M. showed that the excess of phos-
phorus accumulates in tissues. Phosphorus binds with calci-
um and is retained in the bone in large quantities sclerosing 
and destroying bone vascular and nerve endings. Thus, the 
oral cavity appears to be “the gate of infection” that commu-
nicates with the jaw bones through the periodontium [17]. 
In this way the mechanism of overinfection of jaw bones 
can be explained. The high risk of failure or occurrence of 
postreconstruction osteonecrosis in patients who administer 
or have administered narcotic phosphorus substances em-
phasizes the importance of a full preoperative assessment.
Long-term administration of corticosteroids within sys-
temic pathologies has negative impact on the body, i.e. on 
marginal periodontium and alveolar ridge reconstruction. 
Corticosteroid therapy has an adverse effect on the bone sys-
tem and can induce osteoporosis [18]. Regarding the alveo-
lar ridge reconstruction in long-term corticosteroid therapy 
it is reasonable to assess the risk induced by corticosteroid-
induced osteoporosis [19].
After radiotherapy  osteoblasts and osteoclasts decrease 
quantitatively and the terminal differentiation of osteoblasts 
is accelerated. Data published showed that mesenchymal 
stem cells in the bone marrow are quantitatively reduced 
[20]. Vascular sclerosis and fibrosis are characteristic fea-
tures of radiation injury. Spontaneous bone healing is highly 
compromised and reduced in irradiated areas and the physi-
ology of bone regeneration is modified as well [21]. One of 
the most important life-threatening adverse effect is osteo-
radionecrosis. Ionizing radiation limits the vascularization, 
increases the incidence of fibrous union, and leads to high 
morbidity rate. Bone grafts cannot be used when vascular 
system is in poor condition [22]. Therefore, alveolar ridge 
reconstruction should be considered from 12 months after 
the last course of radiotherapy.
Gastric pathologies have a great impact on the oral cavity 
state, as well they affect the rehabilitation after oral surgery. 
Gastroesophageal reflux disease GERD constitutes the risk 
factor for chronic marginal periodontitis; therefore, it can 
influence the outcome of alveolar ridge reconstruction. The 
most reasonable explanation is the reduction of salivary gland 
functioning. Mixed saliva covers all vital internal anatomical 
surfaces with secretions rich in mucin that provide a diffuse 
protective barrier against mechanical, thermal, chemical and 
microbial damage. Saliva also acts as an endogenous antacid 
agent that acts against symptomatic gastroesophageal reflux 
disease. Therefore, the decrease of salivary secretion leads to 
insufficient acid neutralization [23]. Hyposalivation in pa-
tients with GERD has been demonstrated in several studies. 
It was found an association between reduced salivary flow 
and periodontal disease among the elderly [24]. Therefore, 
we can conclude that hyposalivation in GERD may have an 
influence on the development of chronic periodontitis by al-
lowing the proliferation of intraoral bacteria, thus increasing 
the risk of infection of grafts and materials used in alveo-
lar ridge reconstructions. Therefore, dental surgeons should 
manage GERD in patients requiring alveolar ridge recon-
struction.
In 2016, Adachi et al. showed that the degree of endo-
scopic atrophy of the gastric mucosa in patients with mar-
ginal periodontitis was significantly higher compared to 
those without periodontitis [25]. Long-term H. pylori infec-
tion causes not only atrophy of the gastric mucosa, but also 
marginal periodontitis. Therefore, it is reasonable to treat H. 
pylori before alveolar ridge reconstruction. This measure will 
help to control periodontopathic bacteria and prevent com-
plications after reconstruction.
HIV-positive patients may be candidates for alveolar 
bone reconstruction. These immunocompromised patients 
may be incapable for sustained, controlled and effective im-
mune response to exogenous trauma that constitutes a high 
risk for developing further postoperative complications. 
Thus, HIV-positive patients have a high postoperative infec-
tion rate after rehabilitation of maxillofacial trauma (11.8% 
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vs 4.4% HIV-negative) [26]. The hypothesis of a higher risk 
for HIV-infected patients after oral surgery has been pre-
sented [27]. No relationships between complications and vi-
rologic or immunological laboratory parameters were found.
A special category of patients requiring alveolar ridge 
reconstruction are smokers.  Although, smokers may not 
have general pathologies that could influence the outcome 
of alveolar ridge reconstruction there is a risk associated 
with smoking consequences on tissues and structures of the 
oral cavity. Smoking has been associated with increased ac-
cumulation of bacterial plaque; high incidence of gingivitis 
and periodontitis; high rate of tooth loss and increased re-
sorption of the alveolar bone; and poor mucogingival heal-
ing after surgery due to frequent occurrence of refractory 
periodontitis. Several studies have shown that smoking was 
a risk factor for marginal bone loss or implant failure [28]. 
Some authors suggest that better results can be achieved in 
smokers if an aggressive antimicrobial regimen is followed 
[29], however, the results obtained after keeping this regi-
men are not as favorable as those obtained in non-smokers.
Particular attention should be paid to patients aged 60 
years old or over (geriatrics) while performing alveolar ridge 
reconstruction.  Being a geriatric patient is not a contraindi-
cation for implant treatment and alveolar ridge reconstruc-
tion. Healthy elderly patients without systemic conditions 
can have dental implants and there is no evidence that geri-
atric changes of bone metabolism affect directly the osseoin-
tegration. According to Hyo-Jung Lee et al. implant therapy 
in geriatric patients should not be considered a risk factor 
[30]. It is imperative to assess the general state of the geri-
atric patient that is a candidate for oral reconstructive sur-
gery and take a therapeutic decision according to obtained 
results.
The study allowed us to identify some steps (fig. 1) for 
the guidance of specialists that have to elect patients with 
general diseases for alveolar ridge reconstruction [29].
Fig. 1. Decision tree for determining whether the 
patient is a candidate for gBR, based on their systemic 
conditions [29]
The fact that 10% of all patients presented concomitant 
pathologies that can influence the alveolar ridge reconstruc-
tion highlights the importance of anamnesis and a thorough 
preoperative preparation in order to maximize the positive 
outcome of alveolar ridge reconstruction.
Conclusions
The study has shown the existence of: high rate of post-
operative complications after alveolar ridge reconstruction 
in patients with concomitant pathologies, which are able to 
influence the healing process; low complication rate or its 
absence when concomitant pathologies are lacking; patholo-
gies that cannot influence the healing process. Assessment of 
patients with alveolar ridge defects during preparation and 
planning of preimplantation bone reconstruction identified 
a number of concomitant pathologies, more or less noticed 
by the patient, which may remain unclear due to superficial 
study of the patient's condition that is able to influence the 
surgical treatment outcome. These issues can be both intra-
operative and postoperative and lead to failure of surgical 
treatment and further reoperation.
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